dsm-firmenich's Share Repurchase Program Overview
dsm-firmenich, known for its innovation in nutrition, health, and beauty, has embarked on a notable share repurchase program aimed at enhancing shareholder value. The program initially announced a commitment of €1 billion to repurchase shares, with the goal of reducing the company's issued capital and fulfilling obligations under its share-based compensation plans.
Program Details and Financial Commitment
Beginning with an initial commitment of €500 million, the program experienced significant growth. As of April 1, 2025, the company initiated a repurchase program valued at €580 million. This included €80 million earmarked specifically for covering commitments associated with the Group's employee share schemes, and €500 million dedicated to reducing capital.
Increased Investment in Share Repurchase
On June 27, 2025, reflecting the company’s robust financial position and confidence in its growth trajectory, dsm-firmenich announced an increase in the total share repurchase commitment to €1,080 million. This adjustment followed the successful divestiture of a stake in the Feed Enzymes Alliance, showcasing the strategic financial maneuvers by dsm-firmenich to optimize capital allocation.
Recent Repurchase Activity
During the week of July 7 to July 11, 2025, dsm-firmenich reported the repurchase of 293,078 shares. This activity was conducted at an average price of €90.16 per share, which totaled approximately €26.4 million. Cumulatively, the number of shares repurchased under this initiative has reached 4,528,509, at an average price of €93.8, amounting to total expenditures of €424.8 million.
Completion Timeline of the Program
It is anticipated that the comprehensive share repurchase program valued at €1,080 million will reach completion no later than January 30, 2026. This timeline underscores the company’s commitment to enhancing shareholder equity through responsible management of its share structure.
Contacting dsm-firmenich
For inquiries regarding investor relations, dsm-firmenich can be reached via email at investors@dsm-firmenich.com. Media inquiries can be directed to media@dsm-firmenich.com.
About dsm-firmenich
dsm-firmenich is a leading company in the areas of nutrition, health, and beauty. It is dedicated to reimagining, producing, and combining essential nutrients, flavors, and fragrances. The firm serves the world’s expanding population with a focus on sustainability. dsm-firmenich operates from dual headquarters located in Kaiseraugst, Switzerland, and Maastricht, Netherlands. It is publicly traded on the Euronext Amsterdam and has a presence in nearly 60 countries, generating revenues exceeding €12 billion.
Frequently Asked Questions
What is the purpose of dsm-firmenich's share repurchase program?
The program aims to enhance shareholder value by repurchasing shares, thereby reducing issued capital and fulfilling obligations under share-based compensation plans.
How much has dsm-firmenich committed to the share repurchase program?
dsm-firmenich has committed €1,080 million to the share repurchase program, with a part of it aimed at reducing issued capital and covering share-based compensation.
When is the expected completion date of the share repurchase program?
The program is expected to be completed no later than January 30, 2026, according to the company’s latest announcements.
How many shares have been repurchased to date?
As of the latest updates, dsm-firmenich has repurchased a total of 4,528,509 shares under the program.
Where can I find more information about dsm-firmenich?
For additional information, you can visit dsm-firmenich's official website or contact their investor relations and media teams via email.
